Pharma Journalist - Page 60 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Brii Biosciences Licenses BRII-693 Rights to Joincare in Greater China

Jazz Pharmaceuticals Gets EU Approval for Ziihera to Treat Advanced HER2-Positive Biliary Tract Cancer

FDA Grants Priority Review for WINREVAIR Label Update Following ZENITH Trial Results

FDA Grants Accelerated Approval to ZEGFROVY, First Oral EGFR‑Exon‑20 Insertion NSCLC Therapy

Adagene Secures Up to $25M Strategic Investment from Sanofi

Lynozyfic (linvoseltamab-gcpt) Granted FDA Accelerated Approval for Relapsed/Refractory Multiple Myeloma

Riliprubart Earns Orphan Drug Designation in Japan for CIDP

FDA Approves Gamifant as First Treatment for MAS in Still’s Disease

FDA Eases Monitoring Rules, Removes REMS from BMS Cell Therapies

Vetter Breaks Ground on New Clinical Site